Evidence map›Paper›PMID 29093379›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome.

Yuichiro Inagaki, Tatsuya Ito, Tomonori Kato, Yoshitaka Ono, Masashi Sawa

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Coinfection ofHeliyon · 2024
    Article
  3. DisseminatedHeliyon · 2024
    Article
  4. Article
  5. Infection and drug resistance · 2021
    Article
  6. Evidence of an environmental reservoir for emergentNew microbes and new infections · 2020
    Article
  7. The skin and soft tissue infections in hematological patients.Current opinion in infectious diseases · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuichiro InagakiDepartment of Hematology and Oncology, Anjo Kosei Hospital, Japan.
Tatsuya ItoDepartment of Hematology and Oncology, Anjo Kosei Hospital, Japan.
Tomonori KatoDepartment of Hematology and Oncology, Anjo Kosei Hospital, Japan.
Yoshitaka OnoDepartment of Hematology and Oncology, Anjo Kosei Hospital, Japan.
Masashi SawaDepartment of Hematology and Oncology, Anjo Kosei Hospital, Japan.
Anjo Kosei Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium colombiense (M. colombiense) is a member of the Mycobacterium avium complex (MAC). To our knowledge, this is the third case report of an M. colombiense infection. An 80-year-old man, immunocompromised by myelodysplastic syndrome (MDS), developed a skin rash with exfoliation and eruption on his face and scalp. Mycobacteria were detected in pus samples. Broad-range polymerase chain reaction (PCR) revealed the mycobacteria to be M. colombiense. The lesions resolved after daily administration of rifampicin, ethambutol, and clarithromycin. In conclusion, broad-range PCR identified this rare mycobacterium, allowing for the administration of appropriate combination antibiotic therapy.

Indexed as

AgedAged, 80 and overAnti-Bacterial AgentsClarithromycinEthambutolHumansImmunocompromised HostMaleMiddle AgedMycobacteriumMycobacterium InfectionsMyelodysplastic SyndromesRifampinTreatment OutcomeAnti-Bacterial AgentsClarithromycinEthambutolRifampinbroad-range polymerase chain reactionimmunocompromised hostMycobacterium avium complexnontuberculous mycobacteria

Identifiers

PMID29093379
PMCPMC5827328
OpenAlexW2766847466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.